Business
Press Release Sep 23 2023
Strides Pharma Science Limited has informed the Exchange regarding a press release dated September 23, 2023, titled "Strides receives USFDA approval for Icosapent Ethyl Capsules".
About this update from Strides Pharma Science Ltd
Strides Pharma Science Limited has informed the Exchange regarding a press release dated September 23, 2023, titled "Strides receives USFDA approval for Icosapent Ethyl Capsules". View Attachment
View stock analysis, news, and events for Strides Pharma Science Ltd